Researchers using machine learning discovered that variations in microbial load in the gut, influenced by age, sex, diet, and ...

Researchers at University of California San Francisco (UCSF) have developed a single genomic test that can quickly detect ...

Immune cells are capable of detecting infections just like a sniffer dog, using special sensors known as Toll-like receptors, ...

The US Food and Drug Administration (FDA) has awarded the second breakthrough therapy designation (BTD) to Johnson & ...

Nipocalimab is a fully human monoclonal antibody that blocks FcRn and decreases levels of circulating IgG antibodies.

Breakthrough T1D North Texas and Oklahoma, formerly known as JDRF, hosted the Breakthrough T1D Walk at Hunter Park in Tulsa ...

UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver disease associated with ...

Experts made the discovery after analysing hours of YouTube footage of celebrities with the disease - and it paves the way ...

Johnson & Johnson said its nipocalimab treatment for adults living with moderate-to-severe Sjögren's disease has received breakthrough therapy designation from the Food and Drug Administration.

Scientists are working on a way to restore the production of a protein that is essential for communication in the brain and ...

Discover groundbreaking research from Emory University that has revealed that autoantibodies found in the nasal cavity may ...

Vaxcyte (NASDAQ:PCVX) announced that the U.S. FDA cleared the VAX-31 infant Investigational New Drug application and granted ...